ASNDAscendis Pharma A/S
- Market cap
- $16.01B
- as of 2026-10-23
- Latest close
- $243.37
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-05-12
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Bienaime Jean Jacques | Apr 14 | Sep 28 | D · derivative | 9,160 | $172.35 | $1,578,726 | not reported | No | Form 4 |
| Bienaime Jean Jacques | Apr 14 | Sep 28 | A · derivative | 9,160 | $249.84 | $2,288,534 | 9,160 | No | Form 4 |
| Bodenhoff MadsSVP & PAO | Sep 8 | Sep 9 | M | 3,000 | $110.00 | $330,000 | 3,000 | No | Form 4 |
| Bodenhoff MadsSVP & PAO | Sep 8 | Sep 9 | S | 3,000 | $270.19 | Sale −$810,570 | not reported | No | Form 4 |
| Bodenhoff MadsSVP & PAO | Sep 8 | Sep 9 | M · derivative | 3,000 | $110.00 | $330,000 | 687 | No | Form 4 |
| Holtug Lars | Sep 2 | Sep 3 | S | 236 | $264.13 | Sale −$62,335 | 4,000 | No | Form 4 |
| Bienaime Jean Jacques | Aug 14 | Aug 18 | P | 1,100 | $245.85 | Purchase +$270,435 | 2,000 | No | Form 4 |
| Bienaime Jean Jacques | Aug 14 | Aug 18 | P | 900 | $246.91 | Purchase +$222,219 | 2,900 | No | Form 4 |
| Smith Scott ThomasEVP & Chief Financial Officer | Jun 2 | Jun 2 | P | 100 | $219.00 | Purchase +$21,900 | 4,367 | No | Form 4 |
| Smith Scott ThomasEVP & Chief Financial Officer | May 29 | Jun 1 | P | 250 | $223.32 | Purchase +$55,830 | 4,267 | No | Form 4 |
| Bienaime Jean Jacques | May 29 | Jun 1 | P | 200 | $223.76 | Purchase +$44,752 | 600 | No | Form 4 |
| Bienaime Jean Jacques | May 29 | Jun 1 | P | 200 | $222.30 | Purchase +$44,460 | 800 | No | Form 4 |
| Bienaime Jean Jacques | May 29 | Jun 1 | P | 100 | $223.50 | Purchase +$22,350 | 900 | No | Form 4 |
| Bienaime Jean Jacques | May 26 | May 27 | P | 200 | $236.24 | Purchase +$47,248 | 200 | No | Form 4 |
| Bienaime Jean Jacques | May 26 | May 27 | P | 200 | $239.37 | Purchase +$47,874 | 400 | No | Form 4 |
| Jensen Flemming SteenSee Remarks | May 11 | May 12 | S | 19,460 | $238.49 | Sale −$4,641,015 | not reported | No | Form 4 |